Barinthus Biotherapeutics PLBRNS
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 13 institutions reported holding Barinthus Biotherapeutics PL (BRNS) in their 13F filings, down 2 from Q3 2025. 3 opened new positions and 5 sold out. The largest holders were HSG Holding Ltd ($42.2M), M&G PLC ($5.2M) and DC Funds, LP ($450K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Barinthus Biotherapeutics PL
- CUSIP
- 91864C107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $150K |
| Exits | 5 | $2.0M |
All 13F filers, Q3 2025 → Q4 2025: 294,864 shares bought and 1,565,213 shares sold, net −1,270,349 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| HSG Holding Ltd | 2.23% | No change | 1,420,473 | $42.2M |
| M&G PLC | 0.03% | No change | 5,197,349 | $5.2M |
| DC Funds, LP | 30.95% | No change | 642,204 | $450K |
| Renaissance Technologies | 0.00% | Add +115.8% | 143,100 | $100K |
| Johns Hopkins University | 0.01% | No change | 122,237 | $86K |
| Citadel Advisors | 0.00% | New | 118,799 | $83K |
| Baird Financial Group, Inc. | 0.00% | Reduce -1.4% | 105,961 | $74K |
| Rangeley Capital, LLC | 0.05% | New | 84,441 | $59K |
| HighTower Advisors, LLC | 0.00% | No change | 37,450 | $26K |
| Rhumbline Advisers | 0.00% | New | 11,685 | $8K |
| Geode Capital Management, LLC | 0.00% | No change | 11,568 | $8K |
| Morgan Stanley | 0.00% | Reduce -31.1% | 3,406 | $2K |
| UBS Group AG | 0.00% | Add +24146.2% | 3,152 | $2K |
"% of holder's portfolio" is BRNS's weight in each manager's 13F, not the share of Barinthus Biotherapeutics PL the manager owns.